Prosecution Insights
Prosecution Insights
115 pending office actions • 54 art units • 99 examiners • 0 of 115 (0%) have an AI response strategy ready • 104 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 44 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 44 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 7 (6%) |
| §103 only | 30 (26%) |
| §102 only | 3 (3%) |
| §112 only | 10 (9%) |
| Double-patenting only | 5 (4%) |
| Double-patenting + other | 15 (13%) |
| Multi-statute (no §101) | 42 (37%) |
| No statute on record | 3 (3%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VIVLEMORE, TRACY ANN | 5 | 73.0% | +6.7% |
| REDDIG, PETER J | 3 | 58.1% | +39.9% |
| KELLY, ROBERT M | 2 | 73.8% | +24.8% |
| GROOMS, TIFFANY NICOLE | 2 | 58.8% | +46.8% |
| TATGE, LEXUS MARC | 2 | 50.0% | +100.0% |
| YU, DAVID TUYANG | 2 | 100.0% | +0.0% |
| CARTER, SANDRA DILLAHUNT | 2 | 56.1% | +29.7% |
| SPENCER, ANDREA LYNNE MORRIS | 2 | 28.6% | +83.3% |
| REGA, KYLE THOMAS | 2 | 61.8% | +40.7% |
| WESTON, ALYSSA G | 2 | 60.0% | +51.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16435257 | TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR | BRISTOL, LYNN ANNE | 132d overdue |
| 17627260 | DEVICES AND METHODS FOR RAPID SCREENING OF DRUGS OF ABUSE AND OTHER ANALYTES | SVEIVEN, MICHAEL CAMERON | 51d overdue |
| 17617193 | METHODS AND SYSTEMS FOR PARTICLE BASED TREATMENT USING MICRODOSIMETRY TECHNIQUES | DRAPEAU, SIMEON PAUL | 44d overdue |
| 18625699 | METHODS FOR USING ENRICHED EXOSOMES AS A PLATFORM FOR MONITORING ORGAN STATUS | JUEDES, AMY E | 29d overdue |
| 17189970 | MOBILIZED PERIPHERAL BLOOD AS A SOURCE OF MODIFIED IMMUNE CELLS | MIDDLETON, DANAYA L | 18d overdue |
| 18254893 | COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ANGELMAN SYNDROME | YU, DAVID TUYANG | 15d overdue |
| 18560153 | COMPOSITIONS AND METHODS FOR DEBULKING VIRUS OR MICROORGANISM LOAD IN THE ORAL CAVITY | MOAZZAMI, NAGHMEH NINA | 4d overdue |
| 17504500 | GLP-1R AGONIST REDUCES RETINAL INFLAMMATION AND NEURON DEATH SECONDARY TO OCULAR HYPERTENSION | BRADLEY, CHRISTINA | 4d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18431638 | COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS | KELLY, ROBERT M | 97d overdue |
| 18148807 | TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR | REDDIG, PETER J | 66d overdue |
| 18304843 | Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias | KELLY, ROBERT M | 26d overdue |
| 17997110 | COMPOSITIONS AND METHODS FOR REDUCING NUCLEASE EXPRESSION AND OFF-TARGET ACTIVITY USING A PROMOTER WITH LOW TRANSCRIPTIONAL ACTIVITY | SPENCER, ANDREA LYNNE MORRIS | 6d |
| 18392854 | COMPOSITIONS COMPRISING A LECITHIN CHOLESTEROL ACYLTRANSFERASE VARIANT AND USES THEREOF | GROOMS, TIFFANY NICOLE | 15d |
| 18339565 | CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING CELL | REDDIG, PETER J | 55d |
| 18420525 | TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY | REDDIG, PETER J | — |
| 18263085 | COMPOSITIONS AND METHODS FOR TREATMENT OF NIEMANN PICK TYPE A DISEASE | TATGE, LEXUS MARC | — |
| Art Unit | Apps |
|---|---|
| 1638 | 7 |
| 1633 | 6 |
| 1637 | 6 |
| 1636 | 5 |
| 1631 | 5 |
| 1674 | 5 |
| 1646 | 4 |
| 1635 | 4 |
| 1634 | 4 |
| 1658 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19195070 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR IDENTIFYING BIOMARKERS INDICATIVE OF NEURODEGENERATION USING A COVARIANCE NEURAL NETWORK | HANKS, BENJAMIN L | 3684 | §101§103§112 | Non-Final OA | — | Pending | Apr 30, 2025 |
| 19051398 | METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR | HIBBERT, CATHERINE S | 1658 | Other | Non-Final OA | 3d overdue | Pending | Feb 12, 2025 |
| 18949254 | INTRAVASCULAR CERVICAL SYMPATHETIC NERVE STIMULATION SYSTEM | JIAN, SHIRLEY XUEYING | — | §102§103 | Non-Final OA | — | Pending | Nov 15, 2024 |
| 18904575 | Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells | WESTERBERG, NISSA M | 1618 | §103Other | Non-Final OA | 18d overdue | Pending | Oct 02, 2024 |
| 18853162 | BIODEGRADABLE LIPIDOIDS AND COMPOSITIONS AND METHODS OF USE THEREOF FOR LIVER TARGETED DELIVERY | TCHERKASSKAYA, OLGA V | — | §103§112DP | Non-Final OA | — | Pending | Oct 01, 2024 |
| 18846153 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR ASSESSING VISUAL FUNCTION USING VIRTUAL MOBILITY TESTS | SRIDHAR, SAMANVITHA | — | §103 | Non-Final OA | — | Pending | Sep 11, 2024 |
| 18822614 | PUPILLOMETER | LIU, CHU CHUAN | — | §103 | Non-Final OA | — | Pending | Sep 03, 2024 |
| 18771929 | NATURAL AND ARTIFICIAL INTELLIGENCE FOR ROBUST AUTOMATIC ANATOMY SEGMENTATION | LEMIEUX, IAN L | 2669 | §101§102 | Non-Final OA | — | Pending | Jul 12, 2024 |
| 18727953 | COMPOSITIONS USEFUL IN TREATMENT OF METACHROMATIC LEUKODYSTROPHY | WILSON, MICHAEL C | — | §102§112Other | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18765678 | METHOD AND APPARATUS FOR IMPROVING COGNITIVE PERFORMANCE THROUGH CORTICAL STIMULATION | HADDAD, MOUSSA MAHER | 3796 | §102§112Other | Non-Final OA | — | Pending | Jul 08, 2024 |
| 18721234 | PET IMAGING SYSTEM COOLING | FAYE, MAMADOU | 2884 | §103 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18720823 | COMPUTER-IMPLEMENTED METHODS AND ASSOCIATED SYSTEMS FOR DETECTING MALIGNANCY | JACOB, OOMMEN | 3797 | §112 | Non-Final OA | 33d | Pending | Jun 17, 2024 |
| 18675268 | Scalable, Printable, Patterned Sheet Of High Mobility Graphene On Flexible Substrates | MIGGINS, MICHAEL C | 1782 | §102§103DPOther | Final Rejection | 70d | Pending | May 28, 2024 |
| 18670290 | COMPOSITIONS AND METHODS FOR TREATING B-LYMPHOID MALIGNANCIES | LEONARD, ARTHUR S | — | DP | Non-Final OA | — | Pending | May 21, 2024 |
| 18668785 | ROBOTIC MICROCAPSULE ASSEMBLIES WITH EMERGENT MOBILITY FOR TARGETED TREATMENT AND DRUG DELIVERY | YANG, YI-SHAN | 1616 | §103 | Non-Final OA | — | Pending | May 20, 2024 |
| 18625699 | METHODS FOR USING ENRICHED EXOSOMES AS A PLATFORM FOR MONITORING ORGAN STATUS | JUEDES, AMY E | 1644 | §102§112Other | Final Rejection | 29d overdue | Pending | Apr 03, 2024 |
| 18695471 | LIPID NANOPARTICLE (LNP) COMPOSITIONS AND METHODS OF USE THEREOF | ALAM, AYAAN A | 1611 | §102§103Other | Non-Final OA | — | Pending | Mar 26, 2024 |
| 18689656 | Universal Influenza Vaccine and Methods of Use | ZOU, NIANXIANG | — | §102§103§112 | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18431638 | COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS | KELLY, ROBERT M | 1657 | §103Other | Final Rejection | 97d overdue | Pending | Feb 02, 2024 |
| 18293711 | DESIGNER MEMBRANELESS ORGANELLES SEQUESTER NATIVE FACTORS FOR CONTROL OF CELL BEHAVIOR | CORDAS, EMILY ANN | 1632 | §103 | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18292522 | STABILIZED PYROPHORIC MATERIALS FOR ONBOARD HYDROGEN GENERATION BY HYDROLYSIS AND RELATED METHODS | FELTON, AILEEN BAKER | 1734 | §102§112 | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18292247 | COMPOSITIONS AND METHODS FOR ENHANCING CAR T CELL EFFICACY THROUGH THE ENGINEERED SECRETION OF C. PERFRINGENS NEURAMINIDASE | METCALF, MATTHEW CURRAN | — | §102§103§112 | Non-Final OA | — | Pending | Jan 25, 2024 |
| 18420721 | CELLULAR COMPOSITIONS FOR TREATING BACK PAIN | RAHMAN, MASUDUR | 1633 | §102§103 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18420525 | TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY | REDDIG, PETER J | 1646 | §102§103§112Other | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18416271 | TREATMENT OF SKIN LESIONS | SCHMITT, MICHAEL J | 1629 | §103Other | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18413810 | ELECTRODE AND METHOD FOR PRODUCING THE SAME | SARCENO ROBLES, CHRISTIAN MANUEL | 3794 | §102§103 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18392854 | COMPOSITIONS COMPRISING A LECITHIN CHOLESTEROL ACYLTRANSFERASE VARIANT AND USES THEREOF | GROOMS, TIFFANY NICOLE | 1637 | §103§112Other | Non-Final OA | 15d | Pending | Dec 21, 2023 |
| 18542382 | METHOD FOR TESTING AND SCREENING P38 MAP KINASE MODIFIERS | EMCH, GREGORY S | 1678 | §112Other | Non-Final OA | 31d overdue | Pending | Dec 15, 2023 |
| 18570153 | MATERIAL DEPOSITION ONTO AND RECOVERY FROM SURFACES VIA CONTACTLESS, REVERSIBLE DROPLET WETTING/DE-WETTING BY DIELECTRIC CHARGE INJECTION | SUN, CAITLYN MINGYUN | 1795 | §102 | Final Rejection | 2d overdue | Pending | Dec 14, 2023 |
| 18567629 | RECOMBINANT ADENO-ASSOCIATED VIRUSES FOR LESCH-NYHAN DISORDERS AND USES THEREOF | GOMEZ RODRIGUEZ, JULIO WASHINGTON | — | §103§112 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18519972 | METHODS AND COMPOSITIONS FOR TREATING METASTATIC BREAST CANCER AND OTHER CANCERS IN THE BRAIN | ARON, KIMBERLY A | 1633 | DP | Non-Final OA | — | Pending | Nov 27, 2023 |
| 18563707 | MONITORING OF UPPER LIMB MOVEMENTS TO DETECT STROKE | TOTH, KAREN E | 3791 | §103 | Final Rejection | 38d overdue | Pending | Nov 22, 2023 |
| 18560153 | COMPOSITIONS AND METHODS FOR DEBULKING VIRUS OR MICROORGANISM LOAD IN THE ORAL CAVITY | MOAZZAMI, NAGHMEH NINA | 1652 | §102§103§112 | Final Rejection | 4d overdue | Pending | Nov 10, 2023 |
| 18503969 | USE OF MICRORNA-146A AND NANOCERIA CONJUGATE TO IMPROVE WOUND HEALING AND PROMOTE TISSUE REGENERATION | STEVENS, MARK V | 1613 | §103DP | Final Rejection | — | Pending | Nov 07, 2023 |
| 18501859 | Methods and Compositions for Treating, Ameliorating, and/or Preventing Chronic Kidney Disease (CKD) and Complications thereof by Regulating DPEP1, CASP9, ACSS2 and/or FASN | VYAS, KEYUR ANILKUMAR | 1637 | §102§112 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18499922 | MEDICAL IMAGE ANALYSIS PLATFORM AND ASSOCIATED METHODS | ZUBERI, MOHAMMED H | 2178 | §103 | Final Rejection | — | Pending | Nov 01, 2023 |
| 18485352 | COMPOSITIONS USEFUL FOR TREATING SPINAL AND BULBAR MUSCULAR ATROPHY (SBMA) | HUDSON, AMY ROSE | 1636 | §112Other | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18555214 | METHODS TO DETERMINE TREATMENT EFFICACY WITH GAMMA-DELTA T CELLS | LANDSMAN, ROBERT S | 1647 | §103 | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18483862 | Nanoparticle Ink Based Patterning Of Inorganic Materials | YOUNG, WILLIAM D | 1761 | §102§103 | Non-Final OA | — | Pending | Oct 10, 2023 |
| 18554521 | CONTROL OF PROTEIN EXPRESSION WITH TMP-PROTAC COMPOUNDS | MOSHER, ERIC PARKER | 1612 | §103§112 | Non-Final OA | — | Pending | Oct 09, 2023 |
| 18477584 | Enhancing Activity of CAR T Cells by Co-Introducing a Bispecific Antibody | SANG, HONG | 1646 | §112DP | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18549252 | COMPOSITIONS AND METHODS FOR ASSESSING AND TREATING T CELL DYSFUNCTION | PERSONS, JENNA L | 1637 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18548481 | TARGETING T REGULATORY CELLS TO ISLET CELLS TO STALL OR REVERSE TYPE 1 DIABETES | LEE, YIE CHIA | 1642 | §103 | Final Rejection | 71d overdue | Pending | Aug 30, 2023 |
| 18264885 | COMPOSITIONS AND METHODS FOR TREATING PULMONARY ARTERIAL HYPERTENSION (PAH) AND OTHER DISORDERS | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103 | Non-Final OA | — | Pending | Aug 09, 2023 |
| 18365318 | Magnetic Separation Filters And Microfluidic Devices Using Magnetic Separation Filters | GERIDO, DWAN A | 1797 | §102 | Final Rejection | 17d overdue | Pending | Aug 04, 2023 |
| 18263085 | COMPOSITIONS AND METHODS FOR TREATMENT OF NIEMANN PICK TYPE A DISEASE | TATGE, LEXUS MARC | 1637 | §102§103§112 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18260786 | COMPOSITIONS FOR TREATING FRIEDREICH'S ATAXIA | MIANO, JOSEPH PAUL | 1631 | §103DP | Final Rejection | 27d | Pending | Jul 09, 2023 |
| 18339565 | CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING CELL | REDDIG, PETER J | 1646 | §103Other | Final Rejection | 55d | Pending | Jun 22, 2023 |
| 18332150 | USE OF CART19 TO DEPLETE NORMAL B CELLS TO INDUCE TOLERANCE | CHANDRA, GYAN | 1674 | Other | Non-Final OA | 5d overdue | Pending | Jun 09, 2023 |
| 18331331 | HIDDEN ANTIBIOTICS IN THE HUMAN PROTEOME | VARADARAJ, ARCHANA | 1658 | §102§103 | Non-Final OA | — | Pending | Jun 08, 2023 |
| 18266096 | NOVEL METHODS | REDWOOD, CHRISTOPHER EVAN | 1629 | §102§103§112 | Non-Final OA | — | Pending | Jun 08, 2023 |
| 18327981 | Multimodal Proximity and Visuotactile Sensing Through Transmissive Membrane | GRAY, SUNGHEE Y | 2800 | §102§103§112 | Final Rejection | — | Pending | Jun 02, 2023 |
| 18254893 | COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ANGELMAN SYNDROME | YU, DAVID TUYANG | 1635 | §102§103§112Other | Non-Final OA | 15d overdue | Pending | May 30, 2023 |
| 18253017 | TREATMENT OF CASTLEMAN DISEASE | MERTZ, PREMA MARIA | 1674 | §101§102§112 | Non-Final OA | — | Pending | May 15, 2023 |
| 18250764 | A HUMAN VASCULAR INJURY-ON-A-CHIP MODEL OF HEMOSTASIS | ALABI, OYELEYE A | 1797 | §101§102 | Non-Final OA | 56d | Pending | Apr 27, 2023 |
| 18304843 | Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias | KELLY, ROBERT M | 1638 | §112 | Final Rejection | 26d overdue | Pending | Apr 21, 2023 |
| 18297141 | MECHANICAL MESH FIXATION DEVICE AND CURVILINEAR TACK SYSTEM | BACHMAN, LINDSEY MICHELE | 3771 | §112 | Non-Final OA | 73d overdue | Pending | Apr 07, 2023 |
| 18246872 | COMPOSITIONS AND METHODS FOR TREATMENT OF FABRY DISEASE | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | DP | Final Rejection | 73d overdue | Pending | Mar 28, 2023 |
| 18246604 | METHODS AND COMPOSITIONS FOR IN SITU IMMUNE PROFILING OF HEART TRANSPLANT BIOPSIES | CARTER, SANDRA DILLAHUNT | 1674 | §101§112 | Non-Final OA | — | Pending | Mar 24, 2023 |
| 18042729 | VIRAL VECTOR ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES IN FELINES | RAVINDRA, KRISHNA NUGGEHALLI | 1636 | §103Other | Non-Final OA | 99d overdue | Pending | Feb 23, 2023 |
| 18042726 | VIRAL VECTORS ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES | HUMPHRIES, NICHOLAS ADAM | 1631 | DP | Final Rejection | — | Pending | Feb 23, 2023 |
| 18042092 | TARGETING CARTILAGE EGFR PATHWAY FOR OSTEOARTHRITIS TREATMENT | LEE, SIN J | 1613 | §103 | Final Rejection | — | Pending | Feb 17, 2023 |
| 18040971 | RECOMBINANT ADENO-ASSOCIATED VIRUS FOR TREATMENT OF GRN-ASSOCIATED ADULT-ONSET NEURODEGENERATION | THUESON, HANNA MARIE | 1638 | §103 | Final Rejection | 74d overdue | Pending | Feb 07, 2023 |
| 18040648 | NOVEL AAV CAPSIDS AND COMPOSITIONS CONTAINING SAME | SPENCER, ANDREA LYNNE MORRIS | 1631 | §102§103§112DPOther | Non-Final OA | — | Pending | Feb 05, 2023 |
| 18162236 | METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS | GROOMS, TIFFANY NICOLE | 1637 | §103§112DP | Final Rejection | — | Pending | Jan 31, 2023 |
| 18015800 | COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION | VANHORN, ABIGAIL LOUISE | 1636 | §102§103§112 | Final Rejection | 69d | Pending | Jan 12, 2023 |
| 18148807 | TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR | REDDIG, PETER J | 1646 | Other | Non-Final OA | 66d overdue | Pending | Dec 30, 2022 |
| 18061633 | GENE THERAPY FOR OCULAR DISORDERS | VIVLEMORE, TRACY ANN | 1638 | §103§112 | Non-Final OA | — | Pending | Dec 05, 2022 |
| 18000644 | Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis | MIKNIS, ZACHARY J | 1658 | §102§103§112 | Non-Final OA | 26d | Pending | Dec 02, 2022 |
| 18056562 | Polymer Blends Having Improved Ion Conductivity, Devices, and Methods | CULLEN, SEAN P | 1725 | §103§112 | Final Rejection | 26d | Pending | Nov 17, 2022 |
| 17998330 | COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE | RIGA, MICHAEL ANGELO | 1634 | §103§112 | Final Rejection | 34d | Pending | Nov 09, 2022 |
| 18052645 | Anisotropic Pattern Transfer Via Colloidal Lithography | RUMMEL, IAN A | 1785 | §102 | Non-Final OA | — | Pending | Nov 04, 2022 |
| 17997742 | METHODS FOR DETECTION OF PATHOGENIC INFECTIONS USING RED BLOOD CELL-CONTAINING PATIENT SAMPLES | KINSEY WHITE, NICOLE ERIN | 1672 | §103 | Final Rejection | — | Pending | Nov 02, 2022 |
| 17997298 | COMPOSITIONS AND METHODS OF ADAMTS13 CHIMERIC AUTOANTIBODY RECEPTOR CELLS | JOHANSEN, PETER N. | 1644 | §103DPOther | Non-Final OA | 78d | Pending | Oct 27, 2022 |
| 17997108 | COMPOSITIONS AND METHODS FOR REDUCING NUCLEASE EXPRESSION AND OFF-TARGET ACTIVITY USING A PROMOTER WITH LOW TRANSCRIPTIONAL ACTIVITY | ABBOTT, KODYE LEE | 1634 | §112 | Final Rejection | — | Pending | Oct 25, 2022 |
| 17997110 | COMPOSITIONS AND METHODS FOR REDUCING NUCLEASE EXPRESSION AND OFF-TARGET ACTIVITY USING A PROMOTER WITH LOW TRANSCRIPTIONAL ACTIVITY | SPENCER, ANDREA LYNNE MORRIS | 1631 | §103§112Other | Non-Final OA | 6d | Pending | Oct 25, 2022 |
| 17823107 | APPARATUS, METHOD, AND SYSTEM TO DYNAMICALLY DEPLOY WIRELESS INFRASTRUCTURE | GHAFFARI, ABU Z | 2195 | §103 | Non-Final OA | — | Pending | Aug 30, 2022 |
| 17905129 | METHODS OF USING A MULTI-ANALYTE APPROACH FOR DIAGNOSIS AND STAGING A DISEASE | HANEY, AMANDA MARIE | 1682 | §112 | Non-Final OA | 77d overdue | Pending | Aug 26, 2022 |
| 17904903 | TREATING AUTOSOMAL RECESSIVE BESTROPHINOPATHIES AND METHODS FOR EVALUATING SAME | VIVLEMORE, TRACY ANN | 1638 | §102§112Other | Final Rejection | — | Pending | Aug 24, 2022 |
| 17801959 | TISSUE CULTURE MEDIA FOR SURVIVAL AND ENGRAFTMENT OF HUMAN PANCREATIC ISLETS | TICHY, JENNIFER M.H. | 1653 | §103 | Final Rejection | 52d overdue | Pending | Aug 24, 2022 |
| 17904899 | TREATING AUTOSOMAL DOMINANT BESTROPHINOPATHIES AND METHODS FOR EVALUATING SAME | VIVLEMORE, TRACY ANN | 1638 | §102§112DP | Final Rejection | — | Pending | Aug 24, 2022 |
| 17795191 | COMPOSITIONS FOR SMALL MOLECULE CONTROL OF PRECISE BASE EDITING OF TARGET NUCLEIC ACIDS AND METHODS OF USE THEREOF | REGA, KYLE THOMAS | 1636 | §103 | Non-Final OA | — | Pending | Jul 25, 2022 |
| 17794571 | QUANTITATIVE CONTROL OF ACTIVITY OF ENGINEERED CELLS EXPRESSING SPYCATCHER AND SPYTAG UNIVERSAL IMMUNE RECEPTORS | WESTON, ALYSSA G | 1633 | DPOther | Final Rejection | — | Pending | Jul 21, 2022 |
| 17842530 | ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSID AND METHODS OF USE THEREOF | MONTANARI, DAVID A | 1632 | §112 | Final Rejection | — | Pending | Jun 16, 2022 |
| 17738480 | Composite Energetic Material With Self-Regulated Temperature | KRCHA, MATTHEW D | 1796 | §103 | Final Rejection | — | Pending | May 06, 2022 |
| 17769858 | Lipid and Lipid Nanoparticle Formulation for Drug Delivery | GONZALEZ, LUISALBERTO | 1626 | §112DP | Non-Final OA | — | Pending | Apr 18, 2022 |
| 17636950 | UROFLOW MONITORING SYSTEM AND METHOD | MUSTANSIR, ABID A | 3791 | §103 | Final Rejection | 34d | Pending | Feb 21, 2022 |
| 17672438 | COMPOSITIONS AND METHODS FOR INHIBITING BIOFILM DEPOSITION AND PRODUCTION | DABKOWSKI, ERINNE R | 1654 | DP | Final Rejection | — | Pending | Feb 15, 2022 |
| 17627260 | DEVICES AND METHODS FOR RAPID SCREENING OF DRUGS OF ABUSE AND OTHER ANALYTES | SVEIVEN, MICHAEL CAMERON | 1678 | §102§103 | Final Rejection | 51d overdue | Pending | Jan 14, 2022 |
| 17563392 | COMPOSITIONS, COMPRISING IMPROVED IL-12 GENETIC CONSTRUCTS AND VACCINES, IMMUNOTHERAPEUTICS AND METHODS OF USING THE SAME | CARTER, SANDRA DILLAHUNT | 1674 | §112DP | Final Rejection | — | Pending | Dec 28, 2021 |
| 17617193 | METHODS AND SYSTEMS FOR PARTICLE BASED TREATMENT USING MICRODOSIMETRY TECHNIQUES | DRAPEAU, SIMEON PAUL | 2188 | §101§102§103Other | Final Rejection | 44d overdue | Pending | Dec 07, 2021 |
| 17611309 | Methods and Compositions for Treating Obesity and/or Skin Disorders | CHEN, PO-CHIH | 1621 | §112 | Final Rejection | — | Pending | Nov 15, 2021 |
| 17523492 | Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12 | YU, DAVID TUYANG | 1635 | §102§103§112 | Final Rejection | — | Pending | Nov 10, 2021 |
| 17607837 | MICRO-RNA SITE BLOCKING OLIGONUCLEOTIDES FOR THE TREATMENT OF EPILEPTIC ENCEPHALOPATHY AND NEURODEVELOPMENTAL DISORDERS | SULLIVAN, STEPHANIE LAUREN | 1635 | §103 | Final Rejection | 6d | Pending | Oct 29, 2021 |
| 17504500 | GLP-1R AGONIST REDUCES RETINAL INFLAMMATION AND NEURON DEATH SECONDARY TO OCULAR HYPERTENSION | BRADLEY, CHRISTINA | 1654 | §102§103 | Final Rejection | 4d overdue | Pending | Oct 18, 2021 |
| 17603993 | COMPOSITIONS FOR REGULATING AND SELF-INACTIVATING ENZYME EXPRESSION AND METHODS FOR MODULATING OFF-TARGET ACTIVITY OF ENZYMES | REGA, KYLE THOMAS | 1636 | §102§103§112 | Final Rejection | — | Pending | Oct 15, 2021 |
| 17602949 | Compositions and Methods Comprising a High Affinity Chimeric Antigen Receptor (CAR) with Cross-Reactivity to Clinically-Relevant EGFR Mutated Proteins | EDGINGTONGIORDANO, FRANCESCA | 1643 | §102§103DP | Non-Final OA | 37d overdue | Pending | Oct 11, 2021 |
| 17602730 | METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS | BATES, KEENAN ALEXANDER | 1631 | §102§103§112 | Non-Final OA | — | Pending | Oct 08, 2021 |
| 17602277 | METHODS AND COMPOSITIONS FOR PROGRAMMING T CELL DIFFERENTIATION AND ENHANCING T CELL PROLIFERATION | WESTON, ALYSSA G | 1633 | §102§103 | Final Rejection | — | Pending | Oct 07, 2021 |
| 17435365 | ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY | SULLIVAN, STEPHANIE LAUREN | 1635 | §103 | Final Rejection | 27d | Pending | Aug 31, 2021 |
| 17432880 | COMPOSITIONS AND METHODS FOR CRISPR/CAS9 KNOCK-OUT OF CD33 IN HUMAN HEMATOPOIETIC STEM / PROGENITOR CELLS FOR ALLOGENIC TRANSPLANTATION IN PATIENTS WITH RELAPSED - REFRACTORY ACUTE MYELOID LEUKEMIA | TATGE, LEXUS MARC | 1600 | §103§112DPOther | Final Rejection | — | Pending | Aug 20, 2021 |
| 17424363 | MICROCATHETER FOR THERAPEUTIC AND/OR DIAGNOSTIC INTERVENTIONS IN THE SUBARACHNOID SPACE | LUU, TIMOTHY TUAN | 3795 | §103§112 | Non-Final OA | — | Pending | Jul 20, 2021 |
| 17416311 | ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY | CONNORS, ALEXANDRA F | 1634 | §103 | Final Rejection | — | Pending | Jun 18, 2021 |
| 17294401 | COMPOSITIONS AND METHODS FOR THE CYTOPLASMIC DELIVERY OF ANTIBODIES AND OTHER PROTEINS | AEDER, SEAN E | 1642 | §103§112 | Final Rejection | — | Pending | May 15, 2021 |
| 17199926 | Rapid And Ultrasensitive Analyte Detection For Screening In Community Settings | RAMADAN, OMAR | 1678 | §103 | Final Rejection | — | Pending | Mar 12, 2021 |
| 17189970 | MOBILIZED PERIPHERAL BLOOD AS A SOURCE OF MODIFIED IMMUNE CELLS | MIDDLETON, DANAYA L | 1674 | §103§112 | Non-Final OA | 18d overdue | Pending | Mar 02, 2021 |
| 17097997 | COMPOSITIONS FOR DRG-SPECIFIC REDUCTION OF TRANSGENE EXPRESSION | VIVLEMORE, TRACY ANN | 1638 | §102§112DP | Non-Final OA | — | Pending | Nov 13, 2020 |
| 17095370 | MEDICAL DEVICE FOR THE PREVENTION OF THROMBOSIS | LEDERER, SARAH B | 3785 | §103 | Final Rejection | 49d overdue | Pending | Nov 11, 2020 |
| 17046253 | Methods And Compositions Comprising A Viral Vector For Expression Of A Transgene And An Effector | VIVLEMORE, TRACY ANN | 1638 | §103§112 | Non-Final OA | — | Pending | Oct 08, 2020 |
| 16975541 | NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS HAVING REDUCED CAPSID DEAMIDATION AND USES THEREFOR | WANG, RUIXUE | 1672 | §103 | Final Rejection | — | Pending | Aug 25, 2020 |
| 16971995 | METHODS AND COMPOSITIONS COMPRISING CART AND A SMAC MIMETIC | CONNORS, ALEXANDRA F | 1634 | §103§112 | Final Rejection | — | Pending | Aug 21, 2020 |
| 16435257 | TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR | BRISTOL, LYNN ANNE | 1643 | §103§112Other | Non-Final OA | 132d overdue | Pending | Jun 07, 2019 |
| 16317943 | TREATMENT AND PREVENTION OF CYTOKINE RELEASE SYNDROME USING A CHIMERIC ANTIGEN RECEPTOR IN COMBINATION WITH A KINASE INHIBITOR | LU, CHENG | 1642 | §112 | Non-Final OA | 38d overdue | Pending | Jan 15, 2019 |
| 15553805 | ROBUST SMART FILM: REVERSIBLY SWITCHING FROM HIGH TRANSPARENCY TO ANGLE-INDEPENDENT STRUCTURAL COLOR DISPLAY | MILLER, BETHANY MACKENZIE | 1787 | §103§112 | Non-Final OA | — | Pending | Aug 25, 2017 |
| 15327794 | SUBSET-OPTIMIZED CHIMERIC ANTIGEN RECEPTOR-CONTAINING T-CELLS | POPA, ILEANA | 1633 | §103 | Final Rejection | 5d overdue | Pending | Jan 20, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial